News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Misty Dawn Shields: Excellent discussion at TexasLung25 on fusions in NSCLC
Misty Dawn Shields/X
Apr 12, 2025, 11:54

Misty Dawn Shields: Excellent discussion at TexasLung25 on fusions in NSCLC

Misty Dawn Shields, Assistant Professor at Indiana University School of Medicine, shared a post on X:

“Excellent discussion at TexasLung25 on fusions in NSCLC (ALK, ROS1, RET, NTRK, NRG1).

Important points to guide tx:
  • Toxicities (ID, management, risks)
  • CNS efficacy & penetration
  •  Acquired resistance mechanisms

NSCLC

More posts featuring Misty Dawn Shields.

cancer Lung cancer Misty Dawn Shields NSCLC OncoDaily Oncology TexasLung25
Special Coverage
Insight
Apr 15, 2025, 09:02
WHO’s Andre Ilbawi Highlights Global Cancer Medicine Access Challenges
Insight
Apr 15, 2025, 08:45
Guillermo Chantada Opens the Forum on Essential Medicines for Children with Cancer
Blog
Apr 15, 2025, 08:23
Stephen V Liu: Taletrectinib and zidesamtinib promise to move the field of ROS1 NSCLC by addressing resistance and safety
Positive
Apr 15, 2025, 08:03
Rawan Hammad: Thank you to the speakers, moderators, organizers and attendees who made SIOP Asia Riyadh 2025 a success!
Blog
Apr 15, 2025, 07:52
Basel Refky: Presenting in Lebanon, Masterclass in Cairo, and a Publication — A Tough Weekend but Fruitful
Blog
Apr 15, 2025, 07:52
Luchuo Engelbert Bain: The Future is bright - African medical students taking their future into their hands
Blog
Apr 15, 2025, 07:40
Estela Rodriguez: The second-line options for EGFR lung cancer beyond platinum-chemo after best therapies upfront
Blog
Apr 15, 2025, 07:23
EACR about their affiliated journal, Molecular Oncology
Blog
Apr 15, 2025, 07:21
Enrolling for the ComboMATCH Treatment Trial E5 - ECOG-ACRIN Cancer Research Group
Opinion
Apr 15, 2025, 07:10
The NCCN 2025 Breast Cancer Congress recorded presentations are now available
Blog
Apr 15, 2025, 07:09
Roberto Ferrara: Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC
Blog
Apr 15, 2025, 07:04
Imane Bensalim: Honored to have participated in Sim Africa 2025